{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:35:55Z","timestamp":1792254955839,"version":"4.4.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0155315","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T17:30:53Z","timestamp":1464888653000},"page":"e0155315","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors"],"prefix":"10.1371","volume":"11","author":[{"given":"Michael C.","family":"Burger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia S.","family":"Zeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolja","family":"Jahnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Mittelbronn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim P.","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11060-014-1592-1","article-title":"Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution","volume":"120","author":"JJ Mandel","year":"2014","journal-title":"Journal of neuro-oncology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00381-008-0697-2","article-title":"The clinical experience of medulloblastoma treatment and the significance of time sequence for development of leptomeningeal metastasis","volume":"24","author":"PC Hsieh","year":"2008","journal-title":"Childs Nerv Syst"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8","author":"DR Macdonald","year":"1990","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1022536828345","article-title":"Symptomatic spinal dissemination of malignant astrocytoma","volume":"61","author":"R Saito","year":"2003","journal-title":"J Neurooncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1227\/00006123-199010000-00002","article-title":"Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series","volume":"27","author":"FT Vertosick Jr.","year":"1990","journal-title":"Neurosurgery"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00172461","article-title":"Spinal canal metastases: a late complication of glioblastoma","volume":"12","author":"M Schwaninger","year":"1992","journal-title":"J Neurooncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fneur.2014.00220","article-title":"Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management, and outcomes in a series of 34 patients","volume":"5","author":"C Dardis","year":"2014","journal-title":"Frontiers in neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4103\/0028-3886.28122","article-title":"Cases of glioblastoma multiforme metastasizing to spinal cord","volume":"54","author":"M Karaca","year":"2006","journal-title":"Neurology India"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-3019(01)00459-1","article-title":"Spinal leptomeningeal metastasis from cerebral glioblastoma multiforme presenting with radicular pain: case report and literature review","volume":"56","author":"S Alatakis","year":"2001","journal-title":"Surgical neurology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","article-title":"Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis","volume":"17","author":"MJ Glantz","year":"1999","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00701-015-2344-5","article-title":"Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome","volume":"157","author":"JH Noh","year":"2015","journal-title":"Acta neurochirurgica"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1227\/01.NEU.0000043929.31608.62","article-title":"Combined-modality treatment of leptomeningeal gliomatosis","volume":"52","author":"MC Chamberlain","year":"2003","journal-title":"Neurosurgery"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1006377312403","article-title":"ACNU, MTX and 5-FU penetration of rat brain tissue and tumors","volume":"45","author":"TY Huang","year":"1999","journal-title":"Journal of neuro-oncology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.bjc.6601953","article-title":"Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value","volume":"91","author":"U Herrlinger","year":"2004","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.4161\/cc.7.16.6442","article-title":"Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay","volume":"7","author":"P Knizetova","year":"2008","journal-title":"Cell cycle"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1215\/15228517-2007-032","article-title":"Functional VEGF and VEGF receptors are expressed in human medulloblastomas","volume":"9","author":"ML Slongo","year":"2007","journal-title":"Neuro-oncology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s12032-010-9580-6","article-title":"Vascular endothelial growth factor antisense oligonucleotides inhibit leptomeningeal metastasis in vivo","volume":"28","author":"K Li","year":"2011","journal-title":"Med Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/00207454.2012.704456","article-title":"Radiotherapy and bevacizumab for intramedullary and leptomenigeal metastatic glioblastoma: a case report and review of the literature","volume":"122","author":"A Fiorentino","year":"2012","journal-title":"The International journal of neuroscience"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3340\/jkns.2011.49.6.334","article-title":"The clinical features of spinal leptomeningeal dissemination from malignant gliomas","volume":"49","author":"JS Bae","year":"2011","journal-title":"Journal of Korean Neurosurgical Society"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"247873","DOI":"10.1155\/2009\/247873","article-title":"Antiangiogenic therapy in the treatment of recurrent medulloblastoma in the adult: case report and review of the literature","volume":"2009","author":"G Privitera","year":"2009","journal-title":"Journal of oncology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2015.61.5005","article-title":"Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial","volume":"33","author":"T Sandmann","year":"2015","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1470-2045(14)70314-6","article-title":"Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial","volume":"15","author":"W Taal","year":"2014","journal-title":"The Lancet Oncology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11060-014-1486-2","article-title":"Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study","volume":"119","author":"BJ Scott","year":"2014","journal-title":"Journal of neuro-oncology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"PY Wen","year":"2010","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11060-010-0397-0","article-title":"Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab","volume":"103","author":"EM Thompson","year":"2011","journal-title":"Journal of neuro-oncology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1634\/theoncologist.2010-0105","article-title":"Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study","volume":"15","author":"JJ Vredenburgh","year":"2010","journal-title":"The oncologist"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jjco\/hyt051","article-title":"Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors","volume":"43","author":"Y Narita","year":"2013","journal-title":"Japanese journal of clinical oncology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2005.12.002","article-title":"Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy","volume":"65","author":"JD Ruben","year":"2006","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1212\/01.wnl.0000304121.57857.38","article-title":"Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence","volume":"70","author":"AD Norden","year":"2008","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11060-008-9718-y","article-title":"Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan","volume":"91","author":"RM Zuniga","year":"2009","journal-title":"J Neurooncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11060-010-0200-2","article-title":"Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer","volume":"100","author":"KC De Braganca","year":"2010","journal-title":"Journal of neuro-oncology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/omcr\/omv010","article-title":"CPT-11\/bevacizumab for the treatment of refractory brain metastases in patients with HER2-neu-positive breast cancer","volume":"4","author":"S Sengupta","year":"2015","journal-title":"Oxf Med Case Reports"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"MR Gilbert","year":"2014","journal-title":"The New England journal of medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0155315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T05:44:54Z","timestamp":1568007894000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0155315"}},"subtitle":[],"editor":[{"given":"Marta M.","family":"Alonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0155315","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]}}}